Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma

Background: RET/PTC rearrangement, RAS, and BRAF mutations are considered to be mutually exclusive in papillary thyroid carcinoma (PTC). However, although concomitant mutations of RET/PTC, RAS, or BRAF have been reported recently, their significance for tumor progression and survival remains unclear...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zou, Minjing, Baitei, Essa Y., Alzahrani, Ali S., BinHumaid, Faisal S., Alkhafaji, Dania, Al-Rijjal, Roua A., Meyer, Brian F., Shi, Yufei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. 2014
Konular:
Thyroid Cancer and Nodules
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4106383/
https://ncbi.nlm.nih.gov/pubmed/24798740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2013.0610
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller